Neville Mitchell - Sonic Healthcare Non-Executive Independent Director
| SKHCF Stock | USD 17.02 0.69 4.23% |
Director
Mr. Neville John Mitchell serves as NonExecutive Independent Director of the Company. Mr Mitchell is a qualified Chartered Accountant with international healthcare and finance experience. He was Chief Financial Officer and Company Secretary of ASXlisted Cochlear Limited, a worldleading medical device developer, manufacturer and seller of hearing devices. Mr Mitchell was a key member of Cochlears executive team, responsible for the setting and execution of the companys growth strategy from its listing in 1995 until his resignation. Mr Mitchell currently holds nonexecutive director roles with ASXlisted healthcare companies Sirtex Medical Limited and Osprey Medical Inc. . He is a nonexecutive Director of QBiotics, an unlisted public company, and a member of the Australian Board of Taxation and the NSW Governments Medical Device Fund. He has previously performed roles with a number of industry and government committees, including Chairman of the Group of 100, and Chairman, Standing Committee, for the Australian Securities and Investments Commission . since 2017.
| Age | 58 |
| Tenure | 7 years |
| Phone | 61 2 9855 5444 |
| Web | https://www.sonichealthcare.com |
Sonic Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.1111 % which means that it generated a profit of $0.1111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2175 %, meaning that it generated $0.2175 on every $100 dollars invested by stockholders. Sonic Healthcare's management efficiency ratios could be used to measure how well Sonic Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Linda Baddour | Waters | 62 | |
| Todd Sisitsky | IQVIA Holdings | 49 | |
| Frederick Craves | Twist Bioscience Corp | 72 | |
| Robert Chess | Twist Bioscience Corp | 61 | |
| Robert Janoff | Fonar | 90 | |
| Thomas Salice | Waters | 61 | |
| Roberto Mendoza | Prenetics Global | 67 | |
| Egbert Willam | Prenetics Global | 65 | |
| Mary Pendergast | ICON PLC | 65 | |
| Yacov Shamash | Applied DNA Sciences | 67 | |
| Ronald Rittenmeyer | IQVIA Holdings | 73 | |
| Eugene McCague | ICON PLC | N/A | |
| Francis Contino | Mettler Toledo International | 70 | |
| Wah Chu | Mettler Toledo International | 62 | |
| Julie ONeill | ICON PLC | 51 | |
| Colleen Goggins | IQVIA Holdings | 66 | |
| Bryan Brokmeier | Waters | N/A | |
| Jan Johannessen | Twist Bioscience Corp | 62 | |
| Michael Kelly | Mettler Toledo International | 64 | |
| Joshua Bekenstein | Waters | 56 | |
| Connie Harvey | Mettler Toledo International | 52 | |
Management Performance
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 |
Sonic Healthcare Leadership Team
Elected by the shareholders, the Sonic Healthcare's board of directors comprises two types of representatives: Sonic Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonic. The board's role is to monitor Sonic Healthcare's management team and ensure that shareholders' interests are well served. Sonic Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonic Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julian Adler, Chief Imaging | ||
| Mrs Schottdorf, Chief Group | ||
| Neville Mitchell, Non-Executive Independent Director | ||
| BEc CA, Deputy Sec | ||
| Louis Panaccio, Non-Executive Independent Director | ||
| Colin Goldschmidt, CEO, Managing Director, Investor Relations Contact Officer, Executive Director | ||
| Peter Savage, Chief Officer | ||
| Elizabeth Wilson, Independent Non-Executive Director | ||
| Philip Dubois, Executive Director | ||
| Kathryn Spargo, Non-Executive Independent Director | ||
| Stephen Fairy, Global Officer | ||
| Christopher Wilks, Finance Director, Executive Director | ||
| FAICD FRCPA, MD CEO | ||
| BCom FACID, CFO Director | ||
| David Byrne, Chief Laboratory | ||
| Prashan Kulasekera, Assistant Sec | ||
| Mark Compton, Non-Executive Independent Director | ||
| Paul Alexander, Company Secretary |
Sonic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonic Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 11.17 B | |||
| Shares Outstanding | 480.98 M | |||
| Shares Owned By Insiders | 5.09 % | |||
| Shares Owned By Institutions | 38.62 % | |||
| Price To Earning | 13.88 X | |||
| Price To Book | 1.98 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonic Healthcare Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Sonic Healthcare information on this page should be used as a complementary analysis to other Sonic Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Sonic Pink Sheet analysis
When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |